Dr. Lichter Discusses the Growing Concern for the Future of Oncology Practice if the SGR is Not Fixed

In this final segment, Dr. Allen Lichter, CEO of ASCO, discusses the impact SGR has on patients. If a solution cannot be found, Dr. Lichter says that it will be devastating to oncology care. “We are in this together, and want to work together not only as an oncology field, but as a member of the larger community, of medicine and specialty societies to solve this problem,” says Dr. Lichter.
Adult ADHD Compendium
COPD Compendium
Dermatology Compendium
Diabetes Compendium
GI Compendium
Hematology Compendium
Immuno-oncology Compendium
Lipids Compendium
MACRA Compendium
Oncology Compendium
Pain Compendium
Reimbursement Compendium
Rheumatoid Arthritis Compendium
Know Your News
HF Compendium
Managed Care PODCAST